Get startedLog in
    Picture of Telomir Pharmaceuticals logo

    TELO — Telomir Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Telomir Pharmaceuticals Inc expected to post a loss of 8 cents a share - Earnings Preview

    Picture of Telomir Pharmaceuticals logoTelomir Pharmaceuticals
    08/08/2025 21:52
    Telomir Pharmaceuticals Inc TELO.OQ TELO.O is expected to  report resultson August 11 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Telomir Pharmaceuticals Inc is for a loss of 8 cents per share.

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Telomir Pharmaceuticals Inc is $15.50, about 89.2% above its last closing price of $1.67

This summary was machine generated August 8 at 20:52 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

    Recent news on Telomir Pharmaceuticals

    See all news